Isoptin

Quick links to important sections

Isoptin

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Isoptin

What is Isoptin? (Verapamil Hydrochloride Overview)

This section provides a foundational understanding of the medicine Isoptin by outlining its composition, pharmacological classification, and general function, while strictly excluding details on dosage, specific treatments, safety, or administration protocols.

Property Description
Active ingredient Verapamil Hydrochloride
Form Tablet (standard and extended-release), Solution for injection
Pharmacological class Calcium Channel Blocker (CCB)
Common use Cardiovascular regulation (pressure and rhythm)
Origin Synthetic compound (Phenylalkylamine derivative)

What is Isoptin (Verapamil) and What is it Made Of?

Isoptin is a prescription-only medicine whose active ingredient is Verapamil Hydrochloride, a synthetic compound chemically classified as a phenylalkylamine derivative. This compound is a single-ingredient product designed for cardiovascular regulation. The drug is available in several high-level dosage forms, including standard oral tablets and specialized extended-release tablets (such as Isoptin SR), in addition to a sterile solution for injection for intravenous administration. The availability of the extended-release oral formulation is a distinguishing factor, allowing for sustained management of chronic conditions, clinically recognized for supporting long-term compliance.

What Type of Medicine is Verapamil?

Verapamil is definitively categorized as a Calcium Channel Blocker (CCB). Its official pharmacological classification places it in the non-dihydropyridine subgroup. This categorization is key because it defines the medicine's unique capacity to function as both an antiarrhythmic agent and an antihypertensive drug, setting it apart from CCBs that primarily affect peripheral vessels. This class of medicine has an established role in managing rhythm disorders and systemic hypertension. The conclusion drawn from this is that Verapamil is a critical medicine used to stabilize both the rate and the pressure within the circulatory system.

What is the General Purpose of This Drug Class?

The primary general purpose of Verapamil is to establish and maintain cardiovascular balance by modulating the heart's activity and peripheral resistance. Its core function involves inhibiting calcium influx into cardiac and smooth muscle cells, which results in artery relaxation (vasodilation) and a reduction in the heart's rate and contractility.

This mechanism is why the drug is included on lists of essential medicines. This inclusion signals that Verapamil is considered a foundational and effective drug necessary for addressing key cardiovascular health needs globally. By achieving controlled heart rate regulation and relaxing the arteries, Verapamil helps the heart function with less strain, which is the foundational therapeutic goal in managing issues such as recurrent angina.

Regulatory References

  1. WHO Essential Medicines List
  2. Verapamil entry (eEML)

What side effects are possible with Isoptin?

Possible Side Effects and Safety Information: Isoptin

The safety profile of Isoptin (Verapamil) is officially structured by regulatory documents based on the System-Organ Classes affected and the observed frequency of the reactions.

Frequency-Classified Adverse Reactions

The most frequently documented reactions are classified as Common (ge 1/100 to <1/10) and primarily involve the nervous and digestive systems. These include constipation (often the most common), headache, and dizziness. Effects related to the cardiovascular function, such as bradycardia (slow heart rate), hypotension (low blood pressure), and peripheral oedema (swelling in the extremities), are also documented as common.

Frequency Example Adverse Reactions
Common Constipation, Headache, Dizziness, Bradycardia, Hypotension, Peripheral Oedema
Uncommon Palpitations, Nausea, Abdominal pain, Tachycardia

Serious Adverse Reactions and Safety Considerations

The regulatory label explicitly identifies serious adverse reactions related to cardiac function. These include the potential for second- or third-degree atrioventricular (AV) block, sinus arrest, and the worsening or development of cardiac failure. Cases of hepatocellular injury (liver damage) are also officially documented.

Special safety consideration is noted for certain patient populations. For older adults, there is an increased risk for serious conduction effects, partly due to the higher prevalence of conditions like sick sinus syndrome. Additionally, patients with hepatic impairment (liver problems) require close monitoring, as drug clearance is significantly reduced.

Regarding exposure, certain effects like gingival hyperplasia (gum tissue overgrowth) are officially associated with long-term verapamil treatment.

Overdose and Emergency Response

The official regulatory profile for an overdose of Isoptin (Verapamil) is defined by the severe and potentially life-threatening exaggeration of its cardiovascular effects.


Documented Manifestations and Outcomes

Documented manifestations of overdose include profound hypotension, severe bradycardia, and high-degree AV block. Progression can lead to severe cardiovascular events such as cardiogenic shock or asystole, and fatalities have occurred in cases of severe overdosage. Central nervous system effects such as stupor, drowsiness, and confusion are also officially reported in regulatory documents.


Emergency Response Requirements

Any suspected overdose requires that emergency medical help must be sought right away. Due to the high risk of life-threatening cardiovascular events and the fact that no specific antidote is known, immediate intensive supportive measures are necessary. Management involves supportive treatments like administering intravenous calcium and, for severe heart block, procedures such as cardiac pacing. Prolonged hospital monitoring is specifically required for those who have taken sustained-release formulations due to the risk of delayed toxicity. Older individuals and those with pre-existing cardiac impairment are at increased risk of severe toxicity.

Therapeutic Uses of Isoptin

What Isoptin Treats: Main Uses and Benefits

Isoptin (Verapamil) is commonly used to help with symptomatic support across several critical cardiovascular domains, assisting in the management of pressure, heart rate, and the symptomatic burden of heart-related discomfort. The medicine is relevant in conditions characterized by periods of heightened symptoms that require supportive management.

This medication is applied in clinical settings that involve acute or unstable symptom patterns related to hypertension (high blood pressure), various forms of Angina Pectoris (chest pain), and certain supraventricular tachyarrhythmias (fast or irregular heartbeats).

The primary therapeutic role is in assisting with maintaining functional stability. It is relevant in contexts marked by increased discomfort or tension, and often used during phases when symptoms become more noticeable. By assisting with maintaining functional stability of pressure and heart rhythm, Isoptin provides supportive relief when symptoms interfere with routine activities.


Quick Fact: Supportive Management for Cardiovascular Symptom Clusters

Isoptin is commonly used to help manage symptom clusters that may become intense or disruptive, including recurrent chest tightness and pathologically fast heartbeats. The medication assists with maintaining functional stability when symptoms interfere with routine activities.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Isoptin?

Isoptin (Verapamil) eligibility is strictly defined by regulatory authorities based on cardiac status and population group, focusing on absolute contraindications and restrictions.


Populations Who Must Not Use Verapamil (Contraindicated)

Official labeling contraindicates Verapamil use for patients with cardiogenic shock, severe hypotension (systolic pressure typically below 90 mmHg), or severe left ventricular dysfunction (e.g., Ejection Fraction less than 30%). Use is also prohibited in those with hypersensitivity to the drug, or specific conduction defects, including Second- or Third-Degree Atrioventricular (AV) Block or Sick Sinus Syndrome, unless a functioning artificial pacemaker is present. Patients with Atrial Fibrillation/Flutter alongside an accessory bypass tract (like Wolff-Parkinson-White syndrome) must also not use it.


Populations Requiring Conditional Use

Use requires caution and close monitoring for individuals with impaired hepatic (liver) function, often necessitating a substantial dose reduction, and those with impaired renal (kidney) function. For the pediatric population, safety and efficacy are not established for most oral forms, while intravenous use is indicated only for specific arrhythmias. Use during pregnancy is generally not recommended during the first two trimesters, and nursing mothers are advised to discontinue breastfeeding or the medication.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents classify certain combinations with Isoptin (Verapamil) as contraindicated. This prohibition applies to co-administration with medicines such as Dofetilide, Flibanserin, and Ivabradine due to the high documented risk of toxicity or excessive heart rate depression.

The majority of documented drug-drug interactions stem from Verapamil's action as an inhibitor of the enzyme CYP3A4 and the transporter P-glycoprotein (P-gp). This dual activity causes increased plasma concentrations of many co-administered drugs, including the cardiac medicine Digoxin, certain Statins (like Simvastatin and Lovastatin), and Immunosuppressants (such as Cyclosporine).

Conversely, co-administration with CYP3A4 inducers like Rifampicin is documented to cause a dramatic reduction in Verapamil's plasma levels. Pharmacodynamic interactions with Beta-blockers and other Antiarrhythmics carry a documented risk of additive cardiovascular depressant effects, including hypotension and severe bradycardia.

Specific restrictions include a requirement for mandatory dose adjustment or separation for certain drugs, and a prohibition on consumption of Grapefruit Juice, which significantly increases Verapamil exposure. Furthermore, the official labeling notes that interaction severity may be heightened in the presence of hepatic impairment.

Mechanism of Action

How Isoptin Works

Isoptin (verapamil) exerts its action through the direct blockade of L-type Voltage-Gated Calcium Channels ( L-VGCC). These channels, situated on the cell membranes of myocardial tissue, the cardiac conduction system, and arterial smooth muscle, regulate the influx of extracellular calcium ions ( Ca^2+). By inhibiting this ion flow, Verapamil disrupts the essential Excitation-Contraction (E-C) Coupling pathway.

In the heart's electrical system, this inhibition slows the pacemaker activity of the Sinoatrial (SA) node and prolongs impulse transmission across the Atrioventricular (AV) node, resulting in negative chronotropy and negative dromotropy. In the mechanical system, the reduced Ca^2+ availability diminishes the force of myocardial contraction (negative inotropy) and causes vasodilation of the arterial resistance vessels. This systemic arterial relaxation results in a reduction of peripheral vascular resistance ( PVR). The mechanism exhibits use-dependence, with the blockade intensifying during periods of high electrical activity.

Dosage and Administration Information

How Isoptin (Verapamil) is Used

Isoptin, which contains the active ingredient Verapamil, is used through specific administration patterns dictated by the official regulatory labeling. The overall usage protocol is structured into two main delivery paths: oral administration for sustained, long-term management, and intravenous (IV) injection for immediate intervention in acute settings.


Official Administration Guidelines

Oral forms include Immediate-Release (IR) tablets and various Extended-Release (ER) formulations (capsules and tablets). IR tablets are typically taken in divided doses two, three, or four times per day, while the ER forms are generally designed for once-daily administration.

Official dosing is clearly defined: the standard IR starting dose is 80 mg three times daily, while the ER initial dose often ranges from 120 mg to 240 mg once daily. The maximum total daily dose for oral use is 480 mg, though this may vary by specific ER product. Dose adjustments (titration) are typically performed at intervals such as weekly for ER forms, based on response.


Administration Conditions and Special Handling

Administration conditions depend on the formulation. IR tablets can be taken with or without food. However, ER forms, such as Isoptin SR, are often recommended to be taken with food. Critical handling constraints must be followed: Extended-release tablets and capsules must be swallowed whole and not crushed, chewed, or divided, as this compromises the sustained-release mechanism.

For acute IV use, the initial bolus is 5 mg to 10 mg and must be administered slowly over at least two minutes in a setting with continuous ECG and blood pressure monitoring. Dose modifications are specified for certain populations; for example, IV administration in older adults is required to be slowed over at least three minutes.

Recent Clinical Evidence

Isoptin (Verapamil): Summary of Clinical Evidence

Clinical research consistently supports the use of Isoptin (verapamil hydrochloride) across its primary indications: hypertension, angina pectoris, and certain supraventricular tachyarrhythmias (SVTs).


Evidence in Hypertension and Angina

Studies involving patients with essential hypertension (high blood pressure) have observed that verapamil helps reduce systemic vascular resistance. This effect can lead to a decrease in blood pressure, typically without causing a reflexive increase in heart rate (reflex tachycardia).

For angina pectoris (chest pain), trials show that verapamil increases the supply of oxygen to the heart muscle. In patients with stable effort-induced angina, controlled studies have demonstrated an increased exercise duration and a reduction in the reported frequency of anginal episodes compared to placebo. This improvement is linked to the drug's effect on heart rate at rest and during exertion.

Evidence also supports its particular value in managing vasospastic angina (Prinzmetal's angina), where its action as a calcium channel blocker helps to inhibit spasms of the coronary arteries.


Evidence in Arrhythmias

In the management of supraventricular tachyarrhythmias (SVT), verapamil is primarily studied for its ability to slow electrical conduction through the atrioventricular (AV) node of the heart. This action is relevant for controlling the ventricular rate in conditions like atrial fibrillation or atrial flutter with a rapid response.

Randomized clinical trials have shown that verapamil administration can be effective in converting episodes of paroxysmal supraventricular tachycardia (PSVT) back to normal sinus rhythm, especially when the arrhythmia is due to re-entrant mechanisms. Furthermore, research suggests that, following acute treatment, oral verapamil may contribute to a lower rate of early recurrence for PSVT compared to initial treatment alone.

Frequently Asked Questions (FAQ)

Common questions about Isoptin (FAQ)

Q: What are the key high-level differences between Isoptin and common beta-blockers?

Isoptin belongs to a class of medications called calcium channel blockers, which influence both the heart and blood vessels. Official pharmacological data indicates that unlike many beta-blockers, Verapamil uniquely delays the transmission of electrical impulses through the heart’s AV node. This action helps to slow the heart rate and can reduce the force of the heart muscle’s contraction.

Q: Are there any major diet or food restrictions mentioned in official guidance for people taking Isoptin?

Regulatory guidance strongly advises against consuming grapefruit or grapefruit juice while using this medication. Regulatory warnings state that grapefruit can affect the way Verapamil is processed by the body, potentially increasing its concentration in the bloodstream. Otherwise, official patient information does not typically list major general dietary restrictions.

Q: What are the signs of a serious adverse event related to Isoptin according to patient information?

Serious events that require immediate attention are listed in the official patient safety information. These signs can include yellowing of the skin or eyes (jaundice), dark urine, or persistent nausea or vomiting. Other serious signs relate to blood pressure and heart function, such as severe lightheadedness or noticeable changes in heart rhythm that have been reported.

Q: Is Isoptin generally designed to be taken long-term or short-term?

According to official patient information, treatment with Verapamil (Isoptin) is generally intended for the long-term management of chronic conditions such as high blood pressure. Due to its use for chronic conditions, treatment with Verapamil is often continued long-term as part of a sustained management plan.

Q: What does the term 'calcium channel blocker' mean in simple terms for this medicine?

Verapamil is classified as a calcium channel blocker because it prevents calcium from entering the muscle cells of the heart and the walls of the blood vessels. This mechanism of action is associated with two key outcomes: the relaxation of blood vessels, which helps lower blood pressure, and a reduction in the heart's rate.

Q: What over-the-counter pain relievers or cold medicines are known to interact with Isoptin?

Official patient safety information indicates that simple pain relievers like Paracetamol are generally considered safe to take with this medication. However, regulatory warnings note that non-steroidal anti-inflammatory drugs (NSAIDs) may have potential interactions, and their continuous use is generally advised to be managed by a healthcare professional.

Q: Are there any known dermatological (skin-related) side effects associated with Isoptin?

Yes, official clinical trial data and post-marketing reports include several skin-related effects. These have included general skin rash, itching (pruritus), hives (urticaria), and in some reports, hair loss (alopecia).

Q: How long does it typically take for Isoptin to reach its full expected effect?

Immediate-release formulations are described as having a rapid onset of action, with the medication peaking in the bloodstream relatively quickly after taking a dose. However, achieving the full, stable therapeutic benefit for chronic conditions, such as long-term blood pressure control, may require a period of weeks to fully establish.

Q: Does Isoptin have any known interactions with common herbal supplements?

Official interaction warnings specifically mention St John’s wort, noting that it can affect the way Verapamil works in the body. Because many other herbal products have not been formally tested for interactions, regulatory guidance advises that all supplement use should be reviewed by a qualified healthcare professional.

Q: Is fatigue or tiredness a commonly reported experience with Isoptin?

Yes, data collected during clinical trials and post-marketing surveillance indicates that fatigue, general tiredness, and malaise are among the common side effects reported by patients using Verapamil.

Q: Does official labeling address what happens if a dose of Isoptin is missed?

Official patient guidance states that a missed dose is advised to be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the guidance advises to skip the missed dose and resume the regular schedule. Official guidance strictly states that a double dose must not be taken to compensate for a missed dose.

Q: Is there a risk of withdrawal effects mentioned if Isoptin is suddenly stopped? (Descriptive)

Official patient information includes warnings about the abrupt cessation of Verapamil therapy without medical consultation. Stopping the medication suddenly may cause an increase in blood pressure, which could potentially lead to a higher risk of heart attack or stroke.

Q: What are the key safety warnings about driving or operating machinery while taking Isoptin?

Regulatory warnings indicate that caution may be required when performing activities that require alertness, such as driving or operating machinery. This is because the medication can cause dizziness or feelings of lightheadedness, particularly when treatment is first started or after a dose increase.

Q: Does official data suggest Isoptin can cause changes in mood?

Official regulatory data lists depression and emotional depression as uncommon side effects reported by users. Post-marketing reports have also documented psychiatric symptoms, including confusion and, in rare instances, psychotic symptoms.

Q: What information is provided about the use of Isoptin for people with diabetes?

Regulatory patient information notes a potential interaction with certain anti-diabetic medications. Specific regulatory information notes a potential interaction where Verapamil may affect the glucose-lowering effectiveness of certain diabetic medications, such as metformin.

Q: Are there any official reports of Isoptin affecting sexual function?

Post-marketing reports have documented effects on sexual function, specifically reporting erectile dysfunction (impotence). Additionally, gynecomastia (breast enlargement in men) has been reported in older male patients receiving long-term treatment.

Q: What are the official warnings regarding combining Isoptin with alcohol intake?

Official warnings state that Verapamil can increase the effects of alcohol and slow the rate at which the body eliminates it. This combination can also increase the risk of low blood pressure, severe dizziness, and general central nervous system depression.

Q: What is the non-directive guidance regarding activity restrictions while using Isoptin?

Clinical pharmacology data indicates that in patients with normal heart function, Verapamil generally does not alter the heart’s function during physical activity or exercise. Studies also show it can improve exercise tolerance in patients managing chronic stable angina.

How should Isoptin be stored and disposed of?

How to Store and Dispose of Isoptin?

The storage and disposal of Isoptin (verapamil hydrochloride) must strictly follow conditions outlined in official regulatory labeling.

Required Storage Conditions

Isoptin oral tablets must be kept in a tightly closed container and stored at controlled room temperature (20 C to 25 C or 68 F to 77 F). Storage should avoid excess heat and moisture. The solution for injection has specific requirements: it must be protected from light and not frozen.

Stability and Child Safety

For the injection solution, any unused portion must be discarded immediately after withdrawal. All formulations of the medicine must be kept out of the sight and reach of children.

Official Disposal Rules

Unused or expired Isoptin should ideally be returned through a drug take-back program. If one is unavailable, the product must be mixed with an undesirable substance, sealed in a container, and placed in the household trash. The medicine should not be disposed of via wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Isoptin found in:

A-Z Index: